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Autophagy is involved in oligodendroglial
precursor-mediated clearance of amyloid peptide
Wenxia Li1, Yifen Tang1, Zhiqin Fan1, Ya Meng1, Guang Yang1, Jia Luo2* and Zun-Ji Ke1,3*
Abstract
Background: Accumulation of β-amyloid peptides is an important hallmark of Alzheimer’s disease (AD).
Tremendous efforts have been directed to elucidate the mechanisms of β-amyloid peptides degradation and
develop strategies to remove β-amyloid accumulation. In this study, we demonstrated that a subpopulation of
oligodendroglial precursor cells, also called NG2 cells, were a new cell type that can clear β-amyloid peptides in the
AD transgene mice and in NG2 cell line.
Results: NG2 cells were recruited and clustered around the amyloid plaque in the APPswe/PS1dE9 mice, which is
Alzheimer’s disease mouse model. In vitro, NG2 cell line and primary NG2 cells engulfed β-amyloid peptides
through the mechanisms of endocytosis in a time dependent manner. Endocytosis is divided into pinocytosis and
phagocytosis. Aβ42 internalization by NG2 cells was mediated by actin-dependent macropinocytosis. The presence
of β-amyloid peptides stimulated the autophagic pathway in NG2 cells. Once inside the cells, the β-amyloid
peptides in NG2 cells were transported to lysosomes and degraded by autophagy.
Conclusions: Our findings suggest that NG2 cells are a new cell type that can clear β-amyloid peptides through
endocytosis and autophagy.
Keywords: Alzheimer’s disease, β-amyloid degradation, Autophagy, Endocytosis, NG2 cells
Background
The major neuropathological hallmarks of Alzheimer’s
disease (AD) are selective loss of neurons and the forma-
tion of amyloid plaques and neurofibrillary tangles [1]. It
is suggested that accumulation of β-amyloid peptides
(Aβ) plays a central role in pathophysiological procedure
of AD [2,3]. Cellular engulfment of Aβ is an important
mechanism for clearing the harmful protein in the brain;
microglia, astrocyte and neuron are known cell types
capable of clearing Aβ through various putative recep-
tors and transporters [4]. Once internalized, Aβ can be
degraded by various proteases. Autophagy is an import-
ant cellular self-regulatory process involving protein
degradation and recycling. It is essential in maintaining
neuronal homeostasis, and its dysfunction has been dir-
ectly linked to a number of neurodegenerative disorders
[5,6]. Recent finding suggests that Aβ may be degraded
by autophagy/lysosome pathway [7].
In the brain, a subpopulation of glia termed oligo-
dendroglial precursor cells (OPCs). These cells express
NG2 (a chondroitin sulfate proteoglycan), are therefore
called NG2 cells [8,9], they are distinct from astrocytes,
microglia, mature oligodendrocytes and neurons [10].
NG2 cells are abundant in adult brain and comprise 5–
8% of brain cells [11]. Morphologically, NG2 cells have
small cell bodies and multiple branched processes. In
grey matter, these processes tend to have a radial orien-
tation, whereas in white matter, the processes are more
longitudinal and aligned with the nerve fibers. These fine
cellular processes also ensheath synaptic profiles [12].
Neurons also have synaptic junctions with NG2 cells
[13,14]. It is suggested that NG2 cells are a widely dis-
tributed stem-like cells in the adult brain. Usually, NG2
cells are induced to differentiate to glial cells, but under
the appropriate circumstances, they might generate neu-
rons [15,16]. More importantly, NG2 cells become
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rapidly activated in response to a variety of CNS insults,
including physical trauma [17], excitotoxic lesions [18],
viral infection [19], and exposure to chemicals [20].
In this study, we examined the role of NG2 cells in
Aβ42 clearance in mice. We demonstrated that the num-
ber of active NG2 cells was increased and the cells were
clustered around the amyloid plaque. In addition, cul-
tured NG2 cells were able to uptake and clear Aβ42.
Upon internalization most of the Aβ42 is transported to
lysosomes and degraded by autophagy-lysosome pathway.
Our results indicate that NG2 cells can reduce Aβ42 through
endocytosis and degrade Aβ42 by autophagy-lysosome
pathway.
Results
NG2 cells clustered around the amyloid plaque
It has been demonstrated that the number of NG2 cells
as well as the expression of NG2 molecules increases
and the cells become hypertrophic surrounding the
damage sites in various brain injury models [18,20-23].
We examined the localization and morphology of the
NG2 cells in the APPswe/PS1dE9 mice, which express
familial AD-causing mutated forms of human APP
(APPswe, Swedish familial AD-causing mutation) and
presenilin1 (PS1dE9). NG2-positive cells became hyper-
trophic in the cortex of APPswe/PS1dE9 mice (Figure 1A)
and clustered around the amyloid plaques (Figure 1B) in
14-month-old APPswe/PS1 mice. The number of acti-
vated NG2 cells increased around 2 fold in 15-month-
old APPswe/PS1 mice when compared with control mice
(Figure 1C). In addition, the expression of NG2 mRNA in-
creased more than 1.5 fold in 12-month-old APPswe/
PS1dE9 mice compared to age matched wild type mice
(Figure 1D).
Engulfment of Aβ42 by NG2 cells
Microglia and astrocytes are activated and cluster
around amyloid plaques in the brain of AD patients, and
both of the cells, especially microglia, play an important
role in clearing Aβ [24-27]. The Aβ42 variant is more
hydrophobic and more prone to fibril formation than
Aβ40 and it is this longer form that is also the predomin-
ant isoform found in cerebral plaques [4]. Aβ42 was used
in our all experiment. To determine whether NG2 cells
were able to engulf Aβ42, we incubated the primary NG2
cells with fluorescence-labeled Aβ42. The fluorescence-
labeled Aβ42 was visualized within NG2 cells after
24 hours (Figure 2A). Like primary NG2 cells, NG2 cell
line was also able to engulf Aβ42 (Figure 2B). The elec-
tron microscopy further confirmed that the Aβ42 was
distributed in the cytosol of NG2 cells (Figure 2C). The
density of fluorescence-labeled Aβ42 initially increased
after incubation for one hour, and levels further increased
as incubation time increased (Figure 3). Furthermore, the
engulfment of Aβ42 by NG2 cells was concentration-
dependent (Figure 3D).
Actin is involved in the engulfment of Aβ42
The phagocytosis and pinocytosis are two major forms
for cells to uptake extracellular substances. Microglia
can engulf Aβ by macropinocytosis [27]. To determine
the mechanism for the engulfment of Aβ42 by NG2 cells,
we treated the NG2 cell line with nocodazole that causes
depolymerization of microtubules and cytochalasin D that
inhibits actin polymerization. The cytochalasin D reduced
the engulfment of Aβ42 measured by flow cytometry
(Figure 4A). Nocodazole had little effect on Aβ42 internal-
ization after 3 hours of exposure but modestly increased
Aβ42 content following 6 hours of exposure (Figure 4B).
The Aβ42 was degraded by lysosome pathway
To determine the fate of Aβ42 after its internalization,
we examined the Aβ42 content in cellular fraction in NG2
cell line and cell-culture supernatant. Aβ42 in the cellular
fraction increased within 3 hours of Aβ42 incubation then
decreased from 24 hours, indicating that Aβ42 was first in-
ternalized and then degraded (Figure 5A). The Aβ42 in the
culture supernatant decreased over time, supporting that
Aβ42 was taken up by the cells. To determine whether
lysosome pathway is involved in Aβ42 degradation, we
investigated the intracellular distribution of Aβ42 after
its internalization. NG2 cell line was exposed to HiLyte
Fluor™-488-labeled Aβ42 and lysotracker dye for visual-
izing lysosomes. As shown in Figure 5B, Aβ42 is local-
ized in lysosomes. Aβ42 exposure also increased the
mRNA expression of Lysosomal-associated membrane
proteins (LAMP), LAMP1 and LAMP2 (Figure 5C).
Leupeptin and pepstatin, the inhibitors for major cysteine
and aspartyl proteases for lysosomal proteolysis, blocked
the degradation of Aβ42 in the NG2 cells (Figure 5D).
These data suggested that internalized Aβ42 was transported
into the lysosome and degraded by the lysosome-dependent
pathway.
Autophagy involved in the degradation of Aβ42 in NG2
cells
Since autophagy is involved in amyloid-beta peptide me-
tabolism and clearance [7,28-30], we tested whether au-
tophagy regulated the degradation of Aβ42 in NG2 cells.
Aβ42 treatment increased the expression of autophagy re-
lated proteins, including LC3 and beclin1 (Figure 6A).
Furthermore, Aβ42 was co-localized with LC3, suggesting
that they were enclosed by autophagosomes (Figure 6B).
Aβ42 treatment increased the number of mCherry–LC3
puncta–positive cells, suggesting an induction of au-
tophagy (Figure 6C). Autophagy inhibitors, wortmannin
(Figure 6D) and bafilomycin A1 (Figure 6E), decreased
the Aβ42 degradation. The expression of LC3-II dec-
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reased when treated with wortmannin (Figure 6D) and
increased when treated with bafilomycin A1 (Figure 6E).
Beclin1 did not show changes when treated with wort-
mannin (Figure 6D) or when treated with bafilomycin
A1 (Figure 6E) in NG2 cells. Knockdown of beclin1 in
NG2 cells using a beclin1 specific siRNA also increased
the accumulation of Aβ42 (Figure 6F). Together, these
results suggest that Aβ42 could induce autophagy which
directed Aβ42 to lysosome-dependent protein degrad-
ation in NG2 cells.
Discussion
Amyloid plaques, which consist of aggregates of Aβ in the
brain, are the predominant pathological change in AD
patients. The overload of Aβ combined with hyperphos-
phorylated neurofibrillary tangles (NFTs), neuronal loss,
Figure 2 Aβ42 uptake by NG2 cells. Primary NG2 cells (A) and NG2 cell line (B) were plated on coverslips for 18 hours and then incubated with
HiLyte Fluor™ 555/488-labeled Aβ42 (2 μM) for 24 hours. Cells were then fixed and stained with anti-NG2 antibody. Cell nuclei were visualized by
DAPI staining (blue). Aβ42 was engulfed by primary cultured NG2 cells and NG2 cells. Scale bars = 5 μm. C. Aβ42 uptake by NG2 cell line was
shown by transmission electron microscopy (TEM). NG2 cell line were exposed to Aβ42 for 6 hours, stained with anti-Aβ42 IgG antibody followed
by donkey anti-rabbit antibody conjugated to colloidal gold (18 nm particle), then processed by TEM. Internalized Aβ42 was demonstrated. The
inset is an image of internalized Aβ42 with higher magnification. Scale bars = 0.2 μm.
(See figure on previous page.)
Figure 1 The presence of NG2 cells adjacent to the amyloid plaque. A. The presence of NG2 cells in the cortex of 14-month-old APPswe/PS1
mice (top) and control mice (bottom) was demonstrated by immunohistochemistry (IHC) using an anti-NG2 antibody. The amyloid plaque was
demonstrated by thioflavin-S staining. Scale bars = 50 μm. B. A specified area in panel A is shown with higher magnifications. Scale bars = 20 μm.
C. Activated NG2 cells in the hippocampus of APPswe/PS1 mice (6-15-month-old) and age matched control mice were quantified as described under
the Materials and Methods. The results were presented as mean ± SD of five animals. **p < 0.01, ***p < 0.001, compared to age matched control mice.
##p < 0.01, ###p < 0.001, compared to 6-month-old APPswe/PS1 mice. D: The expression of NG2 mRNA in 12-month-old mice was determined by real
time PCR as described under the Materials and Methods. The results were presented as mean ± SEM of five animals. **p < 0.01, compared to age
matched control mice.
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inflammation, and oxidative stress make synaptic dysfunc-
tion and behavioral changes [31,32]. It is important to
understand the mechanisms underlying the clearance of
the amyloid protein in the brain. The levels of Aβ peptides
within the brain are tightly regulated by mechanisms con-
trolling their generation and clearance [3]. In human
CNS, the rate for production and clearance of Aβ is 7.6%
per hour and 8.3% per hour, respectively; therefore there
is no accumulation and deposition of Aβ in the normal
brain [33]. However, even a modest perturbation in Aβ
clearance will result in an imbalance between production
and clearance, and cause an accumulation of Aβ peptides
within the brain and their subsequent deposition into
plaques. The excessive accumulation of Aβ may trigger
the onset of AD, as suggested by the “amyloid hypothesis”
[2]. Activated microglial cells and astrocytes are associated
with amyloid plaques [24,25,27,34,35]. Microglia and as-
trocytes are shown to engulf and degrade Aβ in vitro and
in situ [24,25,27,34]. In this study, we demonstrate that
NG2 cells are recruited and clustered in the area adjacent
to amyloid plaques. The number of active NG2 cells is in-
creased and NG2 mRNA is upregulated. NG2 cells are
able to internalize and degrade Aβ42 and a new cell type
to clear Aβ.
Mechanisms of NG2 cell-mediated Aβ42 uptake
Extracellular substances can be taken up by cells and
transported to intracellular compartments through two
major pathways, the phagocytosis and the pinocytosis.
Phagocytosis is restricted to specialized phagocytic cells
and is responsible for receptor-dependent uptake of large
particles such as bacteria. Pinocytosis encompasses several
distinct mechanisms [36,37]. Macropinocytosis belongs to
dynamin-independent pinocytosis, which can be defined
as a transient, growth factor-induced, actin-dependent
endocytic process that leads to internalization of fluid and
membrane into large vacuoles [38]. Macropinosome for-
mation is an actin based process. Vacuole formation is
Figure 3 The time sequence of engulfment of Aβ42 by NG2 cells. A. NG2 cell line was incubated with HiLyte Fluor™ 488-labeled Aβ42
(400 nM) for the indicated times, and stained with anti-NG2 antibody. Aβ42 appeared inside the cells after 6 hours of Aβ42 incubation. Scale
bars = 5 μm. B-C. Aβ42 engulfed by NG2 cells was quantified with flow cytometry. NG2 cell line (B) and primary NG2 cells (C) were incubated
with HiLyte Fluor™ 488-labeled Aβ42 (400 nM) for the indicated times. The amount of Aβ42 inside cells were quantified by measuring the intensity
of fluoresce with flow cytometry. Data were presented as mean ± SD; *p<0.05, **p<0.01, compared with cells treated with Aβ42 for 0 hours. The
experiments were replicated three times. D. The engulfment of Aβ42 by NG2 cells was concentration-dependent. NG2 cell line was incubated
with HiLyte Fluor™ 488-labeled Aβ42 for the indicated concentrations. The amount of Aβ42 inside cells were quantified by measuring the intensity
of fluoresce with flow cytometry. Data were presented as mean ± SD; **p<0.01, compared with cells treated without Aβ42. The experiments were
replicated three times.
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probably the result of local actin cortex destabilization
[37]. A recent study suggests that microglia internalize Aβ
through fluid phase macropinocytosis [27]. Cytochalasin
D, the inhibitor of actin polymerization, inhibited the en-
gulfment of Aβ42 by NG2 cells, and nocodazole, the in-
hibitor of tubulin polymerization had little effect on Aβ42
engulfment. Microtubules have diverse roles in the cellular
function, including vesicular transportation that facilitates
Aβ42 degradation. They play a role in late steps of endo-
cytosis and are involved in the traffic between early and
late compartments [39]. Translocation of endosomes and
lysosomes occurs along microtubules and is independent
of the intermediate filament and microfilament networks
[40,41]. When the microtubules are depolymerized with
nocodazole, translocation of endosomes and lysosomes is
inhibited, which will affect the transportation of Aβ42 for
its degradation in lysosome, resulting in accumulation
of Aβ42 in cytoplasm. Our data did show nocodazole
modestly increased Aβ42 amount in NG2 cells. These
results suggest that Aβ42 internalization by NG2 cells
may be mediated by actin-dependent macropinocytosis
and the microtubule-dependent process may be in-
volved in its degradation.
The accumulation of Aβ results from the impairment
of balance between producing and clearance of Aβ. So
far, activated microglia and astrocytes are known cell
types that can engulf Aβ. Apart from activated microglia
and astrocytes, neurons can internalize Aβ peptide. Our
results show that both primary NG2 cells and NG2 cell
lines are able to engulf and clear Aβ42, adding a new cell
type to clear Aβ in CNS. The time sequence of NG2 cell
uptake of Aβ42 is similar to that of microglia [27]. Based
on our observation the ability of NG2 cells to clear Aβ is
much weaker than microglia. Therefore, in AD brain,
microglia is the major cell type to clear Aβ. Microglia
expresses a number of putative Aβ transporters, such as
scavenger receptor for advanced glycation end products
(RAGE) [42], formyl peptide receptor-like 1 (FPRL1)
[43,44] and toll-like receptors (TLRs) [45]. These trans-
porters may facilitate microglia-induced clearance of Aβ.
Mandrekar et al. (2009) also demonstrate that microglia
uptake of Aβ is mediated by fluid phase macropino-
cytosis both in vitro and in vivo, and tubulin depoly-
merization and actin polymerization are required for the
process [27]. Our data support that NG2 cell-mediated
Aβ42 uptake depends on actin polymerization but not
tubulin depolymerization.
Cytochalasin D does not completely inhibit Aβ42 intern-
alization in NG2 cells, suggesting that there may be other
pathways that participate in Aβ42 internalization. Aβ can
bind to various membrane biomolecules, including lipids,
proteins and proteoglycans. A number of putative Aβ
transporters have been identified, such as α7 nicotinic
acetylcholine receptor (α7nAChR) [46], apolipoprotein E
(ApoE) receptors [47], members of the low-density lipo-
protein receptor (LDLR) family [48], scavenger receptor
for advanced glycation end products (RAGE) [49], formyl
peptide receptor-like 1 (FPRL1) [43,44] and toll-like recep-
Figure 4 Effect of cytochalasin D and nocodazole on Aβ42 uptake by NG2 cells. NG2 cell line were treated with cytochalasin D (A), an
inhibitor of actin polymerization or nocodazole (B), an agent that disrupts microtubule dynamics for 30 minutes prior to the addition of HiLyte
Fluor™ 488-labeled Aβ42 (400 nM) for the indicated times. The amount of Aβ42 inside cells were quantified by measuring the intensity of fluoresce
with flow cytometry. Data were presented as mean ± SD; **p<0.01, compared with cells without any treatment (Ct). The experiments were
replicated three times.
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tors (TLRs) [4]. It is likely that Aβ also can be internalized
through these receptors or transporters.
Mechanisms of NG2 cell-mediated Aβ42 degradation
Recent studies suggest that autophagy/lysosome pathway
(ALP) is an important and perhaps compensatory mech-
anism for intracellular protein degradation [50,51]. The
accumulation of lysosomes and their hydrolases within
neurons is a well-established neuropathologic feature of
AD. The endosomal-lysosomal system is reported to be
activated in vulnerable neurons in AD brains [52,53]. It
has been suggested that the autophagy/lysosome pathway
is involved in the degradation of Aβ [28]. Autophago-
somes and other prelysosomal autophagic vacuoles were
abundant in AD brains. The transport of autophagic vacu-
oles and their maturation to lysosomes is impaired, re-
sulting in the accumulations of immature autophagic
vacuoles and the inhibition of Aβ clearance [54]. We
showed that Aβ42 was localized to lysosomes after intern-
alization and the expression levels of lysosomal-associated
membrane protein 1 and 2 genes were increased. More-
over, the degradation of Aβ42 was inhibited by lysosomal
proteolysis inhibitors leupeptin and pepstatin A. The ef-
fects of leupeptin supports the role of cysteine protease in
Figure 5 Localization of Aβ42 in lysosomes. A. Aβ42 in cellular fraction in NG2 cell line and culture supernatant was measured by immunoblots.
The results were quantified and presented as mean ± SD; **p<0.01, denote significant difference from that at 0 hours. The experiment was replicated
three times. B. NG2 cell line was incubated with HiLyte Fluor™ 488-labeled Aβ42 (400 nM) for 24 hours, then treated with lysotracker (40 nM) for
30 minutes. Cell nuclei were labeled with DAPI. Aβ42 was co-localized with the signal of lysotracker. Scale bars = 10 μm. C. The mRNA expression of
LAMP1 and LAPM2 in NG2 cell line was measured by RT-PCR after treatment with Aβ42 at the indicated times. Data were presented as mean ± SD;
**p<0.01, compared with cells treated with Aβ42 for 0 hours. The experiments were replicated three times. D and E. NG2 cell line was exposed to Aβ42
for 6 hours, then treated with leupeptin (20 μM) and pepstatin A (20 μM) for 18 hours. The levels of cellular Aβ42, and LC3, and beclin1 proteins were
determined by immunoblotting and normalized to the expression of GAPDH. Data were presented as mean ± SD; *p<0.05, **p<0.01, denote
significant difference from the group treated with Aβ42 alone (Ct). The experiments were replicated three times.
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degrading Aβ has been documented in earlier studies
[55,56]. Pepstatin A increased Aβ42 levels without altering
LC3-II or beclin1 levels. This may be due to the relative
insensitivity of NG2 cells to pepstatin A and a higher con-
centration may be necessary. Pepstatin A is an inhibitor of
aspartic proteinases such as pepsin, cathepsins D and E.
The optimal concentrations for pepstatin A are different
among cell types. Pepstatin A in combination with
Leupeptin did induce more LC3-II accumulation. These
results indicated that Aβ42 was degraded through the lyso-
somal pathway.
Protein degradation by the autophagy/lysosomal path-
way was initiated by the formation of a double-membrane
-limited autophagosome, containing undigested cytoplas-
mic materials. LC3 serves as a specific marker for autoph-
agy in mammalian cells. It has cytoplasmic form (LC3-I)
Figure 6 Autophagy was involved in the degradation of Aβ42. A. NG2 cell line was treated with Aβ42 for specified times. The expression of LC3-II,
and beclin1 was determined by immunoblotting. B. NG2 cell line was incubated with HiLyte Fluor™ 488-labeled Aβ42 (400 nM) for 24 hours, and
immunostained using an anti-LC3-II antibody. Cell nuclei were labeled with DAPI. Scale bars = 5 μm. C. NG2 cell line was transiently transfected with a
mCherry–LC3 plasmid, and autophagosomes were demonstrated by mCherry–LC3 puncta. Scale bars = 5 μm. D. NG2 cell line was exposed to Aβ42 for
6 hours, and then treated with wortmannin at the indicated concentrations for 18 hours. Aβ42, and the expression of LC3, and beclin1 was determined
by immunoblotting (top panel). The results were quantified (bottom panel). E. NG2 cell line was exposed to Aβ42 for 6 hours, then treated with
bafilomycin A1 (0.2 nM) for 18 hours. Aβ42, the expression of LC3, and beclin1 was determined by immunoblotting (top panel). The results were
quantified (bottom panel). F. Top panel: NG2 cell line treated with specific beclin1 siRNA oligonucleotides (siBeclin1-1, siBeclin1-2, siBeclin1-3), scramble
RNA oligonucleotides for 24 hours. The expression of beclin1 was analyzed by immunoblotting. Ct: no treatment; Scr: scramble RNA oligonucleotides.
Middle panel: NG2 cell line was transfected with beclin1 siRNA for 24 hours, then treated with Aβ42 for another 24 hours. Aβ42, the expression of LC3,
and beclin1 was determined by immunoblotting. Bottom panel: Results were quantified. All data were presented as mean ± SD; *p<0.05, **p<0.01,
denote significant difference. All the experiments were replicated three times.
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and autophagosome membrane associated form LC3-II.
LC3 I can be transferred to phophatidylethanolamine (PE)
in the double membrane of the autophagosome and be-
come a lipidated form of LC3 (LC3-II). The ratio of LC3-II
to LC3-I is commonly used as a marker of autophagosome
formation and autophagy activation. Digestion of se-
questered material within autophagosomes is initiated
when lysosomes fuse with the outer membrane of the
autophagosome, forming autolysosome/autophagolysosome
[30]. Beclin1 is a downstream effecter in the autophagy
process and is involved in the recruitment of membranes
to form autophagosomes [57-59]. Reduction expression of
beclin1 increases intraneuronal Aβ accumulation, extra-
cellular Aβ deposition, and neurodegeneration in trans-
genic mice that express human amyloid precursor protein
[7]. We demonstrated that Aβ42 increased the expression
of LC3-II, beclin 1 and LC3 puncta in NG2 cells, indicat-
ing that Aβ42 could activate autophagy. Furthermore,
wortmannin, the chemical inhibitor, and beclin1 siRNA
inhibited autophagy and increased Aβ42 accumulation in
NG2 cells, indicating that Aβ42 degradation was at least
partially mediated by the autophagy/lysosomal pathway.
Conclusions
Amyloid plaques, which consist of aggregates of β-amyloid
peptides in the brain, are the predominant pathological
change in AD patients. An imbalance between Aβ produc-
tion and clearance will result in accumulation of Aβ pep-
tides and subsequent deposition into plaques. Autophagy
may be a protective response to AD during early patho-
genesis and is impaired as the disease progresses. Our
studies demonstrated that NG2 cells were clustered
around amyloid plaque. NG2 cells engulfed Aβ42 through
macropinocytosis. The internalized Aβ42 was degraded by
the autophagy. These findings identified a novel cell type
that could participate in the clearance of Aβ42 in the brain,
which may provide a new insight into the mechanisms of
Aβ42 degradation. It also potentially offers new strategy
for eliminating toxic senile plaques in AD.
Materials and methods
Antibodies and reagents
All culture dishes, plates and flasks were obtained from
Corning. All chemicals, such as Thioflavine S (T1892),
cytochalasin D (C2618), nocodazole (M1404), leupeptin
(L9783), pepstatin A (P5318), wortmannin (W3144),
bafilomycin A1 (B1793) and platelet-derived growth
factor-AA (P3076) were obtained from Sigma-Aldrich
unless otherwise mentioned. Fibroblast Growth Factor
basic, human Animal-Free recombinant (bFGF, GF003-
AF) and Anti-NG2 (rabbit, AB5320) antibodies were
obtained from Chemicon. Anti-beclin1 antibody (rabbit,
3495 s) was obtained from Cell Signaling Technology.
Anti-6E10 (mouse, sig-39320) antibody was obtained
from Signet. Anti- LC3B (rabbit, L7543) was obtained
from Sigma-Aldrich. Anti-GAPDH antibody (kc-5G5)
was obtained from Kangcheng Bio-tech. HiLyte Fluor™
555-labeled beta-amyloid (1–42) (60480–01) or HiLyte
Fluor™ 488-labeled beta-amyloid (1–42) (60479–01) were
obtained from Anaspec. Lysotracker(L7528), trizol
(15596018) and anti-Aβ(1–42) antibody(700254) were
obtained from Invitrogen. Alex-labeled secondary anti-
bodies were obtained from Molecular Probes. Colloidal
gold-affinipure donkey anti-rabbit IgG (18 nm) was
obtained from Jackson Laboratories. Agarose II (low
gelling temperature biotechnology grade, 0815) was
obtained from Amresco.
Animal
A rodent transgenic animal that expresses familial AD-
causing mutated forms of human APP (APPswe, Swedish
familial AD-causing mutation) and presenilin1 (PS1△E9)
(Jackson Laboratory) were used as an AD model. These
animals develop amyloid deposits similar to those found
in brains of humans diagnosed with AD [60,61]. Male SD
rats at postnatal day 1–2 were obtained from Shanghai
SLAC Laboratory Animal Co. Ltd. The procedure for ani-
mal surgery was performed in accordance with the Guide-
lines of Animal Care and Use Committee of the Institute
for Nutritional Sciences, Shanghai Institutes for Biological
Sciences (SIBS), Chinese Academy of Sciences. Every
effort was made to minimize the number of animals
used and their suffering.
Sample collection
For immunohistochemical analysis, animals were anes-
thetized by i.p. injection of chloral hydrate (500 mg/kg)
and were perfused with 10 ml of saline, followed by
100 ml of 4% paraformaldehyde in 0.1 M phosphate buf-
fer (PB, pH 7.2). The brains were removed and post-
fixed in the same fixative overnight, and then transferred
to 30% sucrose for an additional 24 hrs at 4°C. The brain
block was dissected on a Rodent Brain Matrix (ASI In-
struments) and sectioned with a sliding microtome
(Microm Laborgerate GmbH) at the thickness of 40 μm.
For immunoblotting analysis, cultured cells were col-
lected and homogenized in an ice-cold lysis buffer
containing 5 mM EDTA, 0.5% NP-40, 0.1% Triton X-
100, 0.1% SDS, 10 mg/ml PMSF, 10 μg/ml leupeptin and
100 mM sodium orthovanadate in phosphate buffer sa-
line (PBS). Homogenates were centrifuged at 14,000 rev-
olutions per minute (rpm) for 30 minutes at 4°C and the
supernatant fraction was collected. For real-time PCR
analysis, animals were anesthetized by i.p. injection of
chloral hydrate (500 mg/kg) and were perfused with
10 ml of saline. The brains were removed and cerebral
cortex were collected for total RNA extraction.
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Immunohistochemical staining
For immunofluorescence staining, sections were pre-
incubated with 0.3% Triton X-100 in PBS for 10 minutes
and blocked with 1%BSA, 0.1% Triton X-100 for 1 hour.
Then the sections were incubated with anti-NG2 anti-
body (rabbit, 1:500) at 4°C overnight and the Alexa Fluor
555-conjugated goat anti- rabbit IgG (1:1000, Invitrogen,
A-21428) at room temperature for 2 hours. After that,
DAPI (1 μg/ml) was added in the washing buffer for
5 minutes. Brain sections were examined with an Olympus
BX51 microscope (Olympus America Inc.) or Zeiss LSM
510 Meta confocal microscope (Carl Zeiss microImaging
Inc.).
Thioflavin-S staining
The procedure for thioflavin-S staining has been previ-
ously described [62]. Briefly, sections were stained with
0.05% thioflavin-S in 50% ethanol in the dark for 8 mi-
nutes, followed by two rinsing in 80% ethanol for 10 sec-
onds each and three washes in large volumes of distilled
water. Slides were then incubated in a high concentra-
tion of phosphate buffer (411 mM NaCl, 8.1 mM KCl,
30 mM Na2HPO4, 5.2 mM KH2PO4, pH 7.2) at 4°C for
over 30 minutes. After that slides were briefly rinsed
with distilled water, and then sealed with coverslips.
Quantification of activated NG2 cells number
NG2-positive cells with larger cell body, cell body stained
more heavily with antibody against NG2, thicker and
shorter processes were considered as activated NG2 cells
[19,20]. Only NG2 cells with clearly visible nuclei were
counted. The number of activated NG2 cells in the hippo-
campus was quantified by manually counting as previously
described [23,63,64] with some modifications. Five ani-
mals of each group were used for the quantifications . For
each mouse, the brain was sectioned at the thickness of
40 μm. Sections containing hippocampus were collected
from the Bregma level −1.22 mm to −2.3 mm. Every fifth
section was collected and used for NG2 staining. Five sec-
tions per animal were used for quantifications. Digital im-
ages are acquired by a Olympus BX51 microscope system
equipped with a DP72 digital camera (Olympus America
Inc.) using a 10× objective lens. All parameters were held
constant for all sections. The area of hippocampus was
measured by ImageJ (1.44p). The result was presented as
number of activated NG2 cells per unit area (number of
activated NG2 cells/mm2).
Cell cultures
Primary rat oligodendrocyte precursor cells were derived
from the brains of SD rat at postnatal day 1–2 as previ-
ously described [65] with some modifications. Briefly,
cerebral cortices from postnatal day 1–2 SD rats were
dissected, minced and digested. Dissociated cells from
one rat were plated in two 75 cm2 tissue culture flasks
coated by 100 μg/ml Poly-D-Lysine(Sigma-Aldrich,
p7886). Cell cultures were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Invitrogen, 12100–
046) supplemented with 10% fetal bovine serum
(Hyclone, SV30087.02), 10% of horse serum (Invitrogen,
26050–088), 100 U/ml streptomycin and 100 U/ml
penicillin G (Invitrogen, GB15140-122) at 37°C in hu-
midified air with 5% CO2 for 7 to 10 days without chan-
ging the culture medium. After that, the flasks were
sealed and shaken at 230 rpm at 37°C for 3 hours to re-
move microglial cells. The medium was removed and
replaced with 10 ml DMEM containing 10% fetal bovine
serum, 10% of horse serum, 100 U/ml streptomycin and
100 U/ml penicillin G. The flasks were shaken again for
20 hours at 260 rpm at 37°C. The medium containing
floating cells was collected and placed in Petri dishes for
30 minutes at 37°C. The non-adherent cells (oligo-
dendrocyte precursor cells) were collected and replated
on a Poly-D-Lysine-coated 24-well plate at a density of
5 × 104 cells/well. Cells were maintained in SATO
medium containing 1% horse serum, 10 ng/ml platelet-
derived growth factor, and 5 ng/ml bFGF. The NG2 cell
line was kindly provided by Dr. Jacqueline Trotter
(Johannes Gutenberg University of Mainz, Mainz,
Germany) and cultured on Poly-D-Lysine coated cover-
slips in SATO medium containing 1% horse serum [66].
The NG2 cell line was a murine oligodendroglial pre-
cursor cell line and generated by immortalization of mi-
totic oligodendrocyte precursor cells with retroviral
vectors containing the t-neu oncogene. The cell line has
the properties of oligodendrocyte precursor and can dif-
ferentiate into myelin-associated glycoprotein (MAG)-posi-
tive oligodendrocytes. It is a widely used as oligodendrocyte
precursor cells in many in vitro studies [67-69].
Aβ42 preparation
Soluble species of Aβ42 was prepared according to the
instruction of the manufacturer (Anaspec). Briefly, the
lyophilized Aβ42 peptide powder was dissolved in 1.0%
NH4OH (provided by the manufacturer) to get a stock
solution. Immediately dilute this stock solution with 1×
PBS to a concentration of approximately 1 mg/mL. Gently
vortex to mix. Reconstituted peptide was aliquoted into
several freezer vials and stored at −80°C.
Immunocytochemistry
Primary oligodendrocyte precursor cells and NG2 cell
line were plated on coverslips in a 24-well plate at a
density of 5 × 104 and 3 × 104cells/well, respectively for
18 hours. Cells were incubated with HiLyte Fluor™ 555-
or 488-labeled Aβ42 (2 μM) for 24 hours, and then fixed
in 4% paraformaldehyde. After permeabilization with
0.1% Triton X-100, cells were washed with PBS three
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times and blocked in a solution containing 3% BSA and
0.1% Triton X-100 in PBS for 1 hour. Cells were incu-
bated with primary anti-NG2 antibody (1:500) at 4°C
overnight and then washed three times with PBS, incu-
bated with Alexa488- or 555-conjugated goat anti-rabbit
secondary antibodies at a 1:1000 dilution for 1 hour, and
then 1 μg/ml DAPI for 5 minutes. Coverslips were mounted
on slides and observed using a Zeiss LSM 510 Meta con-
focal microscope (Carl Zeiss microImaging Inc.). For
Aβ42’s uptake study, the NG2 cell line were incubated with
HiLyte Fluor™ 488-labeled Aβ42 (400 nM) for the indicated
times. Cells were fixed in 4% paraformaldehyde. After
permeabilization with 0.1% Triton X-100, cells were
blocked in a solution containing 3% BSA and 0.1% Triton
X-100 in PBS for 1 hour. Cells were then processed for
NG2 immunocytochemistry as described above. For visu-
alizing lysosomes, the cells were labeled with lysotracker
(40 nM, 30 minutes) and then fixed, permeabilized and
stained with DAPI.
Transmission electron microscopy
Immunoelectron microscopy was performed as de-
scribed previously [70,71]. NG2 cell line treated with
Aβ42 for 6 hours was collected and fixed with 2.5% glu-
taraldehyde in 0.1 M phosphate buffered saline (PBS;
pH 7.4) at room temperature for 1 hour and washed 3
times with PBS. The cell pellets were then embedded in
2% agarose II and postfixed with 1% Osmium tetroxide
at room temperature for 1 hour. The fixed cell pellets
were rinsed three times with distilled water and three
times with PBS. The pellets were dehydrated through an
ethanol (EtOH) dilution series up to 100% EtOH and
then infiltrated in propylene oxide/ Epon812 resin mix-
ture. Then the pellets were infiltrated in 100% Epon812
for 1 hour. Subsequently, the pellets were embedded in
100% Eponate resin and sectioned. Ultrathin sections
were treated with 1% sodium periodate for 10 minutes.
After washed with ddH2O, sections were blocked in 2%
FBS in PBS without Ca2+/Mg2+ for 30 minutes and incu-
bated with rabbit anti-Aβ42 IgG antibody (1:250) overnight
at 4°C followed by donkey anti-rabbit antibody conjugated
to colloidal gold (18 nm particle for Aβ42 (1:20), Jackson
Laboratories) for 2 hours at room temperature. Sections
were double-stained with uranyl acetate and lead citrate,
and examined under a JEOL JEM1230 electron micro-
scope (JEOL).
Quantification of Aβ42 by flow cytometry
Quantification of Aβ42 by flow cytometry was performed
as previously described with some modifications [27].
Briefly, primary oligodendrocyte precursor cells and NG2
cell line were plated at a density of 2 × 105 cells/well in a
6-well plate overnight. The cells were incubated with
HiLyte Fluor™ 488-Aβ42 (400 nM) for the indicated times.
For nocodazole and cytochalasin D treatment, NG2 cells
were preincubated with 150 nM nocodazole and 5 μg/ml
cytochalasin D for 30 minutes and then incubated with
HiLyte Fluor™ 488-Aβ42 (400 nM) for the indicated times.
Cells were removed by the treatment of 0.01% trypsin
(Invitrogen, 25200–072), centrifuged at 1,000 g for 5 minutes,
and washed with PBS twice. After that, cells were re-
suspended in PBS for the analysis using a FACScan
cytometer (BD Biosciences) equipped with a FITC signal
detector FL1 (excitation 488 nm, green).
Immunoblotting
The procedure for immunoblotting was previously de-
scribed [72]. Briefly, proteins were loaded into the lanes
of a sodium dodecyl sulfate polyacrylamide gel (SDS-
PAGE) or tricine sodium dodecyl sulfate polyacrylamide
gel (Tricine-SDS-PAGE). The proteins were separated by
electrophoresis and transferred to nitrocellulose mem-
branes (0.45 or 0.22 μm, Schleicher & Schuell). The
membranes were blocked with 5% nonfat dry milk in
0.01 M PBS (pH 7.4) and 0.05% Tween-20 (TPBS) at
room temperature for 1 hour. Subsequently, the mem-
brane was incubated with primary antibodies directed
against target proteins overnight at 4°C. The final dilu-
tions for primary antibodies were: 6E10 (1:1,000), LC3
(1:2,000), and Beclin1 (1:2,000). After three quick washes
in TPBS, the membranes were incubated with secondary
antibodies conjugated to horseradish peroxidase (Amersham)
diluted at 1:5,000 in TPBS for 1 hour. The immuno-
complexes were detected by the enhanced chemilumin-
escence method (Amersham, RPN2106). The density of
immunoblotting was quantified with the software of
Quantity One (Bio-Rad Laboratories).
Assaying Aβ42 degradation
The analysis for Aβ42 degradation in the NG2 cell line
was performed as previously described [24]. NG2 cell
line (5 × 105cells/well) cultured in Sato medium
containing 1% horse serum was exposed to human Aβ42
(400 nM). Aβ42 levels in cell-culture supernatants and
adherent cells were determined by immunoblotting. For
some experiments, NG2 cell line was incubated with
HiLyte Fluor™ 488-Aβ42 (400 nM) for 6 hours, followed
by the treatment of leupeptin (20 μM), pepstatin A
(20 μM), wortmannin, and bafilomycin A1(0.2 nM) for
18 hours. The protein levels of Aβ42, LC3, and beclin1
were determined by immunoblotting.
Real-time PCR
NG2 cell line was incubated with HiLyte Fluor™ 488-
labeled Aβ42 (400 nM) for the indicated times. Total
RNA extraction and reverse transcription for NG2 cell
line and cerebral cortex were performed as previously
reported [72] with some modifications. Briefly, total
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RNA was extracted using Trizol reagent (Invitrogen,
15596018). After treated with RNase-free DNase I
(Roche Applied Science, 10104159001), first strand
cDNA was synthesized with M-MLV reverse transcript-
ase (Promega, M1701) and Oligo-dTs (Promega, C1101).
Real-time quantitative PCR was conducted with ABI
Prism 7500 Sequence Detection System according to the
instruction of the manufacturer (Applied Biosystems).
Dissociation curve analyses were performed using the
instrument’s default setting immediately after each PCR
run to ensure specificity. The expression level of target
genes was normalized to the actin gene. The primers
which were used for real time PCR are provided in the
following Table 1.
Small RNA interference
Small interfering RNAs were synthesized by Shanghai
GenePharma Co., Ltd. The siRNA sequences for mouse
beclin1, siRNA-1: sense 5′-GAGGAGCCAUUUAUUG
AAACUCG-3′ and antisense 5′-CGAGUUUCAAUAAA
UGGCUCCUC-3′; siRNA-2: sense 5′-GGACAACAAG
UUUGACCAUGC-3′ and antisense 5′-GCAUGGUCAA
ACUUGUUGUCC-3′; for siRNA control, oligos with no
matching GeneBank sequence were used: sense 5′-GC
GACGAUCUGCCUAAGAU-3′ and antisense 5′-AUC
UUAGGCAGAUCGUCGC-3′. The pairs of siRNA oligo-
nucleotides were prepared as a 20 μM stock. For transient
transfection, NG2 cell line was cultured in six-well plates
to 80% confluence and transfected with Lipofectamine™
RNAiMAX (Invitrogen, 13778–150) according to the
manufacturer’s instructions. After transfection, the cells
were left for another 24 hours before they were used for
experiments.
Quantification of the mCherry-LC3 puncta
Human microtubule-associated protein 1 light chain 3
beta (MAP1LC3B, Gene ID: 81631) was cloned from a
cDNA of HEK-293 (ATCC, CRL-1573) with forward pri-
mer (5′- CAA CAA GCT TCC ATG CCG TCG GAG
AAG ACC −3′) and reverse primer (5′- CGC GGA TCC
TTA CAC TGA CAA TTT CAT CCC G −3′). The
nucleotide sequence was inserted into mCherry-C1
vector (a gift from Dr. Kang, JS, INS, SIBS, CAS)
at the Hind III and BamH I restriction sites. The
plasmid was verified by sequencing (Invitrogen). The
mCherry–LC3 was transiently transfected NG2 cell
line using Lipofectamine™ 2000 (Invitrogen, 11668–
019) following the manufacturer’s instructions. After
transfection, the cells were treated with HiLyte
Fluor™ 488-labeled Aβ42 (400 nM) for 18 hours.
After that, cells were fixed in 4% paraformaldehyde,
permeabilized with 0.1% Triton X-100, and incubated
with DAPI (1 μg/ml) for 5 minutes. Cells were ex-
amined using the Olympus BX51 microscope system
equipped with a DP72 digital camera (Olympus
America Inc.).
To analyze the formation number of autophagosomes,
we determined mCherry–LC3 (the plasmid was kindly
provided by Dr. Jiansheng Kang) puncta in cells. The cells
were classified as (a) cells with diffuse mCherry–LC3 fluor-
escence or with few mCherry–LC3 puncta (<20 dots/cell)
and (b) cells with numerous mCherry–LC3 puncta (>20
dots/cell), representing autophagosomes [73]. At least 200
cells per sample were scored for each condition in three
independent experiments. The percentage of mCherry-
LC3–positive cells with mCherry-LC3 punctate dots were
calculated [74].
Statistical analysis
Statistical analysis was assessed by ANOVA followed by
Student–Newman–Keuls analyses. An unpaired t test was
used for the analysis of quantitative data of bafilomycin
A1. Two-way ANOVA was used for the analysis of quanti-
tative data of activated NG2 cells number. Data were
presented as means ± SD. Difference in which p < 0.05 was
considered statistically significant.
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Table 1 Primers for real time PCR
Gene Primer
Mouse-LAMP1-sense CAGCACTCTTTGAGGTGAAAAAC
Mouse-LAMP1-antisense ACGATCTGAGAACCATTCGCA
Mouse-LAMP2-sense ATATGTGCAACAAAGAGCAGGT
Mouse-LAMP2-antisense TGCCAATTAGGTAAGCAATCACT
Mouse-NG2-sense CCCCCCCATACCCATGTC
Mouse-NG2-antisense CGATCGGAAATAACCTGAAGCT
Mouse-Actin-sense CAACGAGCGGTTCCGAT
Mouse-Actin-antisense GCCACAGGATTCCATACCCA
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